Arcutis Biotherapeutics, Inc.
ARQT· Nasdaq
ARQTArcutis Biotherapeutics, Inc.
Quarterly figures for Arcutis Biotherapeutics, Inc., with source filings when available.
30 quarters. Mar 31, 2019 to Jun 30, 2026. USD.
Arcutis Biotherapeutics, Inc. has filed its 10-Q within 28 to 45 days of period end across its last 8 quarters. The 10-K runs 47 to 79 days.
Arcutis Biotherapeutics, Inc. · CIK 1787306 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 5, 2026 · after-hours | Aug 5, 2026 | 36 d | 10-Q | $129.86M | +59.3% | $0.11 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| — |
| May 6, 2026 |
| 36 d |
| 10-Q |
| $105.40M |
| +60.1% |
| -$0.09 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 25, 2026 · after-hours | Feb 25, 2026 | 56 d | 10-K | $129.50M | +81.5% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 28, 2025 · pre-market | Oct 28, 2025 | 28 d | 10-Q | $99.22M | +121.7% | $0.06 | |
| Q2 2025 | Jun 30, 2025 | Aug 6, 2025 · after-hours | Aug 6, 2025 | 37 d | 10-Q | $81.50M | +164.1% | -$0.13 | |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 · after-hours | May 6, 2025 | 36 d | 10-Q | $65.85M | +32.8% | -$0.20 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 25, 2025 · after-hours | Feb 25, 2025 | 56 d | 10-K | $71.36M | +427.6% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 6, 2024 · after-hours | Nov 6, 2024 | 37 d | 10-Q | $44.76M | +17.4% | -$0.33 | |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 · after-hours | Aug 14, 2024 | 45 d | 10-Q | $30.86M | +494.6% | -$0.42 | |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 · after-hours | May 14, 2024 | 44 d | 10-Q | $49.57M | +1,682.4% | -$0.32 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 27, 2024 · pre-market | Feb 27, 2024 | 58 d | 10-K | $13.53M | +356.8% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 3, 2023 · pre-market | Nov 3, 2023 | 34 d | 10-Q | $38.11M | +5,156.4% | -$0.73 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · after-hours | Aug 8, 2023 | 39 d | 10-Q | $5.19M | — | -$1.16 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · after-hours | May 9, 2023 | 39 d | 10-Q | $2.78M | — | -$1.31 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 28, 2023 · after-hours | Feb 28, 2023 | 59 d | 10-K | $2.96M | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 8, 2022 | 39 d | 10-Q | $725.00K | — | -$1.89 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · after-hours | Aug 4, 2022 | 35 d | 10-Q | $0.00 | — | -$1.31 | |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 · after-hours | May 5, 2022 | 35 d | 10-Q | $0.00 | — | -$1.27 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 22, 2022 · after-hours | Feb 22, 2022 | 53 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 4, 2021 · after-hours | Nov 4, 2021 | 35 d | 10-Q | $0.00 | — | -$1.14 | |
| Q2 2021 | Jun 30, 2021 | Aug 5, 2021 · after-hours | Aug 5, 2021 | 36 d | 10-Q | — | — | -$0.84 | |
| Q1 2021 | Mar 31, 2021 | May 4, 2021 · after-hours | May 6, 2021 | 36 d | 10-Q | — | — | -$0.76 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | Feb 16, 2021 · after-hours | Feb 16, 2021 | 47 d | 10-K | — | — | -$0.79 | |
| Q3 2020 | Sep 30, 2020 | Nov 5, 2020 · after-hours | Nov 5, 2020 | 36 d | 10-Q | — | — | -$1.01 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 11, 2020 | 42 d | 10-Q | — | — | -$0.94 | |
| Q1 2020 | Mar 31, 2020 | — | May 12, 2020 | 42 d | 10-Q | — | — | -$1.15 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Mar 19, 2020 | 79 d | 10-K | — | — | -$6.13 | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | — | — | -$7.56 | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | — | — | -$4.69 | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | — | — | -$4.08 | |
